Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05830942 · ClinicalTrials.gov registry record · NA
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
A NA study of Cognitive Dysfunction and Mobility Limitation, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 2
- Study locations
NCT05830942: Recruiting NA study of Cognitive Dysfunction and Mobility Limitation, sponsored by University of Florida.
NCT05830942 is a NA study of Cognitive Dysfunction and Mobility Limitation that is actively recruiting participants, run by University of Florida. The registered enrollment target is 120 participants, below the 1,990-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05830942, a NA study of Cognitive Dysfunction and Mobility Limitation, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
Declines in cognitive function and walking function are highly intertwined in older adults. A therapeutic approach that combines complex (cognitively engaging) aerobic walking exercise with non-invasive electrical brain stimulation may be effective at restoring lost function. This study tests whether electrical stimulation of prefrontal brain regions is more beneficial than sham stimulation.
Primary Outcome
change in walking speed from baseline to post intervention (or follow-up) timepoint
Conditions Studied
Interventions
- BEHAVIORAL Walking Exercise
- DEVICE Prefrontal Active tDCS
- DEVICE Prefrontal Sham tDCS
Study Locations (2)
Florida
- University of Florida - Gainesville
- Brooks Rehabilitation - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-04-15 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT05830942 shows while recruiting
NCT05830942 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,990-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Cognitive Dysfunction appearing as the primary indexed condition, and to 3 interventions - of which Walking Exercise is the first listed.
NCT05830942 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05830942 about?
NCT05830942 is a clinical study titled "Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults". Declines in cognitive function and walking function are highly intertwined in older adults. A therapeutic approach that combines complex (cognitively engaging) aerobic walking exercise with non-invasive electrical brain stimulation may be effective at restoring lost function. This study tests whethe...
What is the current status of trial NCT05830942?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-04-15. Estimated completion is 2027-04-30.
What conditions does trial NCT05830942 study?
This clinical trial studies the following conditions: Cognitive Dysfunction, Mobility Limitation, Frail Elderly.
What interventions are being tested in trial NCT05830942?
The interventions under investigation include: Walking Exercise (BEHAVIORAL), Prefrontal Active tDCS (DEVICE), Prefrontal Sham tDCS (DEVICE).
Who is sponsoring clinical trial NCT05830942?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05830942 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05830942's enrollment target sits among peer trials
120 20th of 45 higher than 25 of 45 other Cognitive Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
RECRUITING · NA
-
Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment
RECRUITING · NA
-
High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
-
Strengthening Neuro-Cognitive Skills for Success in School, Work and Beyond
RECRUITING · NA
-
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI